Adenosine receptors, heart rate, and cardioprotection

Cardiovascular Research

Volumn 62, Issue 3, 2004, Pages 447-449

  Mangoni, Matteo E ^a   Barrère Lemaire, Stéphanie ^a  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; POTASSIUM;

ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR DISEASE; CELL ACTIVITY; CELL FUNCTION; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; GENE THERAPY; HEART ARRHYTHMIA; HEART CONDUCTION; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; HEART RATE; HEART RHYTHM; HUMAN; NONHUMAN; PHENOTYPE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PURKINJE FIBER; RECEPTOR DENSITY; REGULATORY MECHANISM; SINUS NODE; STIMULATION; TRANSGENE;

ADENOSINE; ANIMALS; GENE THERAPY; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RECEPTORS, PURINERGIC P1;

EID: 2442566376     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.03.021     Document Type: Editorial

References (15)

1. Fabritz L., Kirchhof P., Fortmüller L., Auchampach J.A., Baba H.A., Breithardt G., et al. Gene dose-dependent atrial arrhythmias, heart block and brady-cardiomiopathy in mice overexpressing A3-adenosine receptors. Cardiovasc. Res. 62:2004;500-508
2. Mubagwa K., Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52:2001;25-39
3. Ely S., Berne R. Protective effects of adenosine in myocardial ischemia. Circulation. 85:1992;893-904
4. Mubagwa K., Mullane K., Flameng W. Role of adenosine in the heart and circulation. Cardiovasc. Res. 32:1996;797-813
5. Wang Q.-D., Pernow J., Sjoquist P.-O., Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc. Res. 55:2002;25-37
6. Peart J., Headrick J.P. Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects. Cardiovasc. Res. 58:2003;589-601
7. Baxter G.F. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc. Res. 55:2002;483-494
8. Leesar M.A., Stoddard M., Ahmed M., Broadbent J., Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:1997;2500-2507
9. Maddock H.L., Mocanu M.M., Yellon D.M. Adenosine A3 receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H1307-H1313
10. Heide R.S.V., Reimer K.A. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc. Res. 31:1996;711-718
11. Matherne G.P., Linden J., Byford A.M., Gauthier N.S., Headrick J.P. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc. Natl. Acad. Sci. 94:1997;6541-6546
12. Liang B.T., Jacobson K.A. A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc. Natl. Acad. Sci. 95:1998;6995-6999
13. Kirchhof P., Fabritz L., Fortmuller L., Matherne G.P., Lankford A., Baba H.A., et al. Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am. J. Physiol. Heart Circ. Physiol. 285:2003;145-153
14. Black R.G. Jr., Guo Y., Ge Z.-D., Murphree S.S., Prabhu S.D., Jones W.K., et al. Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. Circ. Res. 91:2002;165-172
15. Salvatore C., Jacobson M., Taylor H., Linden J., Johnson R. Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. 90:1993;10365-10369